STLNW Starling Oncology, Inc. - Warrant
NASDAQ close Oct 2, 2026
$0.04
· of 52w range
· above low
· to high
$0.0252w low
$0.0752w high
your badges
52W Range
$0–$0
Analyst Rating
·
Price Target
·
P/E
·
ROE
·
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
STLNW Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.04
52W Range
$0–$0
STLNW Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Company insiders 16 insiders · 6 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Daniel Virnich | Chief Executive Officer | May 21, 2025 D | 1,787,309 | 0 | 0 | $0 |
| Robert Ross Carter | Chief Financial Officer | May 21, 2025 D | 235,174 | 0 | 0 | $0 |
| Mihir Shah | Chief Financial Officer | Dec. 14, 2023 P | 328,122 | 0 | 0 | $0 |
| Jeremy Castle | Chief Operating Officer | May 21, 2025 D | 247,031 | 0 | 0 | $0 |
| Matthew P Miller | Chief Operating Officer | March 17, 2023 A | 242,992 | 0 | 0 | $0 |
| Yale Podnos | Chief Medical Officer | May 21, 2025 D | 234,336 | 0 | 0 | $0 |
| Brad Hively | Director | Aug. 21, 2026 S | 411,976 | 0 | 1 | $-1,945,533 |
| Gabriel Ling | Director | Dec. 26, 2023 A | 69,057 | 0 | 0 | $0 |
| Karen Marie Johnson | Director | Dec. 26, 2023 A | 115,185 | 0 | 0 | $0 |
| Anne Mcgeorge | Director | Dec. 26, 2023 A | 127,346 | 0 | 0 | $0 |
| Maeve O'Meara | Director | Dec. 26, 2023 A | 109,104 | 0 | 0 | $0 |
| Mohit Kaushal | Director | Dec. 26, 2023 A | 121,253 | 0 | 0 | $0 |
| Mark L Pacala | Director | Dec. 26, 2023 A | 135,029 | 0 | 0 | $0 |
| Richard A Barasch | Director | Dec. 26, 2023 A | 337,193 | 0 | 0 | $0 |
| Ravi Sarin | Director | March 17, 2023 A | 75,427 | 0 | 0 | $0 |
| Chernett Jorey | 10% owner | Aug. 13, 2026 S | 10,660,858 | 1 | 1 | $77,856 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.